ECSP077332A - Nuevo producto, procedimiento e intermediarios de preparación de derivados de azetidina - Google Patents

Nuevo producto, procedimiento e intermediarios de preparación de derivados de azetidina

Info

Publication number
ECSP077332A
ECSP077332A EC2007007332A ECSP077332A ECSP077332A EC SP077332 A ECSP077332 A EC SP077332A EC 2007007332 A EC2007007332 A EC 2007007332A EC SP077332 A ECSP077332 A EC SP077332A EC SP077332 A ECSP077332 A EC SP077332A
Authority
EC
Ecuador
Prior art keywords
derivatives
intermediaries
azetidine
procedure
preparation
Prior art date
Application number
EC2007007332A
Other languages
English (en)
Inventor
Stephane Mutti
Michel Lavigne
Luc Grondard
Joel Malpart
Joerg Rieke-Zapp
Veronique Crocq-Stuerga
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of ECSP077332A publication Critical patent/ECSP077332A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nuevo procedimiento de preparación de derivados de azetidina como la N-{1-[bis-(4-clorofenil)metil]azetidin-3-il}-N-quinol-6-il-metilsulfonamida y de su clorhidrato y de la N-{1-[bis-(4-clorofenil)metil]azetidin-3-il}-N-(3,5-difluorofenil)-metilsulfonamida.
EC2007007332A 2004-10-14 2007-03-21 Nuevo producto, procedimiento e intermediarios de preparación de derivados de azetidina ECSP077332A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0410844A FR2876688B1 (fr) 2004-10-14 2004-10-14 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine
PCT/FR2005/002490 WO2006040465A2 (fr) 2004-10-14 2005-10-10 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Publications (1)

Publication Number Publication Date
ECSP077332A true ECSP077332A (es) 2007-04-26

Family

ID=34954419

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007332A ECSP077332A (es) 2004-10-14 2007-03-21 Nuevo producto, procedimiento e intermediarios de preparación de derivados de azetidina

Country Status (21)

Country Link
US (1) US7687493B2 (es)
EP (1) EP1805167A2 (es)
JP (1) JP2008516932A (es)
KR (1) KR20070063544A (es)
CN (1) CN101039931A (es)
AR (1) AR051390A1 (es)
AU (1) AU2005293454A1 (es)
BR (1) BRPI0516507A (es)
CA (1) CA2583992A1 (es)
EA (1) EA011408B1 (es)
EC (1) ECSP077332A (es)
FR (1) FR2876688B1 (es)
IL (1) IL181904A0 (es)
MA (1) MA29513B1 (es)
MX (1) MX2007003923A (es)
NO (1) NO20072192L (es)
SG (1) SG155193A1 (es)
TN (1) TNSN07097A1 (es)
TW (1) TW200630358A (es)
WO (1) WO2006040465A2 (es)
ZA (1) ZA200702528B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045539B (zh) * 2021-03-30 2021-12-07 苏州大学 2-(4,4-二氯-1-(8-喹啉基)-2-氮杂环丁基)羧酸酯衍生物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709887D0 (en) * 1987-04-27 1987-06-03 Univ Alberta Alkyl azodicarboxylates
US5530134A (en) * 1994-09-06 1996-06-25 Synphar Laboratories Inc. Synthesis of anabaseine, salts and derivatives thereof
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
BRPI0113146B8 (pt) * 2000-08-10 2021-05-25 Mitsubishi Pharma Corp "derivados de prolina e composição farmacêutica que os compreende".
CN1874991A (zh) * 2003-08-29 2006-12-06 小野药品工业株式会社 能够结合s1p受体的化合物及其药物用途

Also Published As

Publication number Publication date
EA011408B1 (ru) 2009-02-27
MX2007003923A (es) 2007-06-07
SG155193A1 (en) 2009-09-30
KR20070063544A (ko) 2007-06-19
EA200700840A1 (ru) 2007-08-31
ZA200702528B (en) 2008-07-30
FR2876688A1 (fr) 2006-04-21
AR051390A1 (es) 2007-01-10
MA29513B1 (fr) 2008-06-02
TW200630358A (en) 2006-09-01
TNSN07097A1 (fr) 2008-06-02
AU2005293454A1 (en) 2006-04-20
US20070270463A1 (en) 2007-11-22
WO2006040465A2 (fr) 2006-04-20
IL181904A0 (en) 2007-07-04
CN101039931A (zh) 2007-09-19
BRPI0516507A (pt) 2008-09-16
US7687493B2 (en) 2010-03-30
FR2876688B1 (fr) 2007-03-16
CA2583992A1 (fr) 2006-04-20
JP2008516932A (ja) 2008-05-22
WO2006040465A3 (fr) 2006-08-10
NO20072192L (no) 2007-04-27
EP1805167A2 (fr) 2007-07-11

Similar Documents

Publication Publication Date Title
ATE469897T1 (de) Indazolcarbonsäureamidverbindungen
TNSN08089A1 (en) Substituted benzimidazoles and methods of preparation
GEP20094785B (en) Pyrrolopyrazoles, potent kinase inhibitors
UA95641C2 (en) Hydroxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
ATE405608T1 (de) Blockförmige hydroxyethylzellulose, derivate daraus, herstellungsverfahren dafür und verwendungen davon
MY155036A (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
MX2007011023A (es) 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3.
UA89787C2 (ru) Фторгликозидные производные пиразолов, лекарственное средство, которое содержит их, и их применение
IL189666A0 (en) Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
ATE441646T1 (de) 5-ht4-rezeptoragonistenverbindungen
WO2006133104A3 (en) Benzoimidazolone-carboxamide compounds as 5-ht4 receptor agonists
DE602005014566D1 (de) Chinolinon-carboxamid-verbindungen
TW200505896A (en) Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist
TW200833660A (en) Synthesis of pyrrolidine compounds
TW200503619A (en) Use of isoindolinone derivatives as insecticides
MX2007010769A (es) Compuestos de quinolina como agonistas de receptor 5-ht4.
WO2006079720A8 (fr) Nouveaux derives d1oximes heterocycliques, leur procede de preparation et leur utilisation comme agents hypoglycemiants et hypoli pemiants
MY148880A (en) N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression
ECSP077332A (es) Nuevo producto, procedimiento e intermediarios de preparación de derivados de azetidina
TW200626542A (en) Novel process and intermediates for preparing n-(1-benzhydrylazetidin-3-yl)-n-phenylmethylsulfonamide derivatives
MY150988A (en) Novel derivatives of ( bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors
UY29166A1 (es) Nuevo producto, procedimiento e intermediarios de preparación de derivados de azetidina
MY143574A (en) Carbamate compounds as 5-ht4 receptor agonists
UA96570C2 (ru) Лиганды н3-рецептора гистамина и их терапевтические применения
UA88794C2 (en) Pyrrolopyrazoles, potent kinase inhibitors